Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Voyageur Pharmaceuticals Ltd V.VM

Alternate Symbol(s):  VYYRF

Voyageur Pharmaceuticals Ltd. is a Canada-based company engaged in the development of barium and iodine Active Pharmaceutical Ingredients (API) and offers high-performance imaging contrast agents. The Company is focused on vertically integrating the barium and iodine contrast market, and aims at producing its own barium, iodine, and endo fullerenes. The Company’s products include SmoothX, SmoothHD, SmoothLD, VisionHD, VisionLD and V-Gas. SmoothX (2%w/v) is a contrast medium for use in computed tomography (CT) of the gastrointestinal tract. VisionHD is a high-density (98% w/w) barium powder suspension tailored for double-contrast radiographic examination of the gastrointestinal tract, esophagus, stomach and duodenum. It also owns a 100% interest in the Frances Creek barium sulfate (barite) project, which is a rare grade mineral suitable for the pharmaceutical marketplace that is intended to replace the current synthetic products with quality imaging products.


TSXV:VM - Post by User

Comment by postie1on May 10, 2022 4:40pm
108 Views
Post# 34671941

RE:RE:RE:Product launch in April

RE:RE:RE:Product launch in AprilThis was posted today on another site. How accurate it is I do not know but for those who want to do some inquiring it provides some info to ask.


"This will turn around. Things are moving along (slowly, but moving). Hang in there, we are nearing the finish line. They got Canadian Health Care Approval last year, but have since been working on an "expiry date" for it, can't start any sales till that is done. 2 of the 4 are complete and 2 are remaining (expecting to be done soon). Once that is done they can start sales in Canada. And they mentioned in the last NR that they are starting FDA approval for the US and that submission should be announced in the next few weeks (is my guess). Once they announce it is submitted it is "up to" 90 days for approvals for that. Then US sales start and that right there is where this will take off."
<< Previous
Bullboard Posts
Next >>